van Leeuwen Marina T, Gurney Howard, Turner Jennifer J, Turner Sandra L, Pearson Sallie-Anne, Laaksonen Maarit A, Harnett Paul, Balakrishnar Bavanthi, Sabanathan Dhanusha, Vajdic Claire M
Centre for Big Data Research in Health, University of New South Wales, Sydney, NSW, 2052, Australia.
Faculty of Medicine and Health Science, Macquarie University, Sydney, NSW, 2109, Australia.
Cancer Epidemiol. 2016 Aug;43:15-21. doi: 10.1016/j.canep.2016.05.006. Epub 2016 May 26.
Germ cell tumour (GCT) aetiology is uncertain and comprehensive epidemiological studies of GCT incidence are few.
Nationwide data on all malignant GCTs notified to Australian population-based cancer registries during 1982-2011 were obtained. Age- and sex-specific, and World age-standardised incidence rates were calculated for paediatric (0-14) and adult (15+) cases using the latest WHO subtype classification scheme. Temporal trends were examined using Joinpoint regression.
There were 17,279 GCTs (552 paediatric, 16,727 adult). Age-specific incidence in males (all histologies combined) was bimodal, with peaks during infancy for most sites, and second, larger, peaks during young adulthood. Incidence of ovarian tumours peaked at age 15-19. Around half of paediatric tumours were extragonadal, whereas adult tumours were mostly gonadal. Yolk sac tumours and teratomas predominated in infants, whereas germinomas became more frequent towards adulthood. Increasing incidence trends for some adult gonadal tumours have stabilised; the trend for male extragonadal tumours is also declining.
Broad similarities in the shape of age-specific incidence curves, particularly for gonadal, central nervous system, and mediastinal tumours provide epidemiological support for commonalities in aetiology among clinically disparate GCT subtypes. Differences in peak ages reflect underlying subtype-specific biological differences. Declining incidence trends for some adult gonadal tumours accords with the global transition in GCT incidence, and supports the possibility of a reduction in prevalence of shared aetiological exposures.
生殖细胞肿瘤(GCT)的病因尚不确定,且关于GCT发病率的全面流行病学研究较少。
获取了1982年至2011年期间澳大利亚基于人群的癌症登记处通报的所有恶性GCT的全国性数据。使用世界卫生组织最新的亚型分类方案,计算了儿童(0 - 14岁)和成人(15岁及以上)病例的年龄和性别特异性以及世界年龄标准化发病率。使用Joinpoint回归分析时间趋势。
共有17279例GCT(552例儿童病例,16727例成人病例)。男性(所有组织学类型合并)的年龄特异性发病率呈双峰模式,大多数部位在婴儿期出现峰值,其次在青年期出现更大的峰值。卵巢肿瘤的发病率在15 - 19岁达到峰值。约一半的儿童肿瘤为性腺外肿瘤,而成人肿瘤大多为性腺肿瘤。卵黄囊瘤和畸胎瘤在婴儿中占主导地位,而生殖细胞瘤在成年期更为常见。一些成人性腺肿瘤的发病率上升趋势已趋于稳定;男性性腺外肿瘤的趋势也在下降。
年龄特异性发病率曲线形状的广泛相似性,特别是对于性腺、中枢神经系统和纵隔肿瘤,为临床不同的GCT亚型病因的共性提供了流行病学支持。峰值年龄的差异反映了潜在的亚型特异性生物学差异。一些成人性腺肿瘤发病率的下降趋势与GCT发病率的全球转变一致,并支持共同病因暴露患病率降低的可能性。